Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Berglind Osk Einarsdottir
BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Related publications
Inhibitors of Pan-Pi3k Signaling Synergize With BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
Frontiers in Oncology
Cancer Research
Oncology
Rechallenge With Checkpoint Inhibitors in Metastatic Melanoma
JDDG - Journal of the German Society of Dermatology
Dermatology
BET Bromodomain Inhibitors With One-Step Synthesis Discovered From Virtual Screen
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Recurrent Pneumonitis in Patients With Melanoma Treated With Immune Checkpoint Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
Resistance Mechanisms in Melanoma to Immuneoncologic Therapy With Checkpoint Inhibitors
Immune Checkpoint Inhibitors in Melanoma: Review and Update
Journal of the Portuguese Society of Dermatology and Venereology
AurkA Inhibitors Enhance the Effects of B-Raf and MEK Inhibitors in Melanoma Treatment
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Combining BET and HDAC Inhibitors Synergistically Induces Apoptosis of Melanoma and Suppresses AKT and YAP Signaling
Oncotarget
Oncology
Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology